OpenURL Connection Search

Select item for more details and to access through your institution.

Tumors Sharply Increased after Ceasing Pazopanib Therapy for a Patient with Advanced Uterine Leiomyosarcoma: Experience of Tumor Flare.
Published in:
2017
By:
- Tanigawa, Terumi;
- Morisaki, Shintaro;
- Fukuda, Hisanobu;
- Yoshimura, Shuichiro;
- Nakajima, Hisayoshi;
- Kotera, Kohei
Publication type:
Case Study
Gene Expression Profile for Predicting Survival in Advanced-Stage Serous Ovarian Cancer Across Two Independent Datasets.
Published in:
PLoS ONE, 2010, v. 5, n. 3, p. 1, doi. 10.1371/journal.pone.0009615
By:
- Yoshihara, Kosuke;
- Tajima, Atsushi;
- Yahata, Tetsuro;
- Kodama, Shoji;
- Fujiwara, Hiroyuki;
- Suzuki, Mitsuaki;
- Onishi, Yoshitaka;
- Hatae, Masayuki;
- Sueyoshi, Kazunobu;
- Fujiwara, Hisaya;
- Kudo, Yoshiki;
- Kotera, Kohei;
- Masuzaki, Hideaki;
- Tashiro, Hironori;
- Katabuchi, Hidetaka;
- Inoue, Ituro;
- Tanaka, Kenichi
Publication type:
Article
Efficacy of palonosetron plus dexamethasone in preventing chemotherapy-induced nausea and emesis in patients receiving carboplatin-based chemotherapy for gynecologic cancers: a phase II study by the West Japan Gynecologic Oncology Group (WJGOG 131).
Published in:
Journal of Gynecologic Oncology, 2018, v. 29, n. 5, p. 1, doi. 10.3802/jgo.2018.29.e77
By:
- Shin Nishio;
- Satomi Aihara;
- Mototsugu Shimokawa;
- Akira Fujishita;
- Shuichi Taniguchi;
- Toru Hachisuga;
- Shintaro Yanazume;
- Hiroaki Kobayashi;
- Fumihiro Murakami;
- Fumitaka Numa;
- Kohei Kotera;
- Naofumi Okura;
- Naoyuki Toki;
- Masatoshi Yokoyama;
- Kimio Ushijima
Publication type:
Article

Found: 3

Tumors Sharply Increased after Ceasing Pazopanib Therapy for a Patient with Advanced Uterine Leiomyosarcoma: Experience of Tumor Flare.

Gene Expression Profile for Predicting Survival in Advanced-Stage Serous Ovarian Cancer Across Two Independent Datasets.

Efficacy of palonosetron plus dexamethasone in preventing chemotherapy-induced nausea and emesis in patients receiving carboplatin-based chemotherapy for gynecologic cancers: a phase II study by the West Japan Gynecologic Oncology Group (WJGOG 131).